Published in Cancer Weekly, November 10th, 2009
"This efficiently inhibited tumor growth and prolonged survival. In addition, surviving mice developed a long-lasting memory response against the original tumor when re-challenged with live tumor cells," wrote H.F. Lv and colleagues, Medical College.
The researchers concluded: "Intravenous administration of dendritic cells and natural killer cells may be a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.